Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or depression (by MDS2) on a single MDHAQ.

导出 LinkOut

翻译打印收藏纠错

作者： Juan,Schmukler ^[1] ; Tengfei,Li ^[2] ; Kathryn A,Gibson ^[3] ; Rosa M,Morla ^[4] ; George,Luta ^[2] ; Theodore,Pincus ^[5]

作者单位： Division of Rheumatology, Department of Medicine, Rush University School of Medicine, Chicago, IL 60612, United States. ^[1] Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University, Washington, DC 20057, United States. ^[2] Department of Rheumatology, Liverpool Hospital, Ingham Research Institute, University of New South Wales, Sydney, NSW 2170, Australia. ^[3] Department of Rheumatology, Hospital Clinic Universitari de Barcelona, Institut d´investigacions Biomèdiques August Pi i Sunyer, 08036 Barcelona, Spain. ^[4] Division of Rheumatology, Department of Medicine, Rush University School of Medicine, Chicago, IL 60612, United States. Electronic address: tedpincus@gmail.com. ^[5]

关键词 MDHAQ Multidimensional health assessment questionnaire, FAST4, Fibromyalgia assessment screening tool, MDS2, Depression, RA, SpA, AxSpA, PsA PATGL Patient global assessment

主题词人类(Humans);纤维肌痛(Fibromyalgia);抑郁(Depression);关节炎, 类风湿(Arthritis, Rheumatoid);炎症(Inflammation);疾病严重程度指数(Severity of Illness Index)

DOI 10.1016/j.semarthrit.2022.152151

PMID 36586208

发布时间 2023-01-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交